Sensitive Skin Syndrome
Conditions
Interventions
Intervention Group:After the subject was anesthetized, one tube of Bole Da 30% supramolecular salicylic acid (7g/tube) was first applied for 5 minutes (no dilution and complete penetration required),
Control Group :Subjects received only gold radiofrequency microneedling treatment after anesthesia.
At-home care: Lanrun Repairing Lotion (trade name: Lanrun Medical Skin Healing Biofilm Cream Dressin
Sponsors
Nanjing Yijia Aesthetic Clinic
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1) Diagnostic criteria for Sensitive Skin Syndrome: The skin easily exhibits symptoms such as burning, episodic flushing, and/or stinging, pruritus, and tightness upon mild external stimulation, with or without persistent erythema; AND a score of =5 on the SSS-7 Scale (Appendix 1). 2) Age between 18 and 60 years. 3) Participants voluntarily join this clinical study and provide written informed consent.
Exclusion criteria
Exclusion criteria: 1) Secondary sensitive skin (e.g., skin sensitivity associated with dermatoses such as rosacea, seborrheic dermatitis, steroid-induced dermatitis, contact dermatitis, atopic dermatitis, or lupus erythematosus tumidus) that may confound trial results; 2) Known allergy to the investigational product or hyperreactive constitution; 3) Pregnant, planning pregnancy, or lactating women; 4) Use of systemic medications within 4 weeks prior to the trial: antibiotics (e.g., minocycline, doxycycline), ß-adrenergic blockers (e.g., carvedilol), corticosteroids, endocrine regulators, or other systemic drugs (e.g., hydroxychloroquine); 5) Topical application of fusidic acid cream, azelaic acid, brimonidine, or similar agents within 2 weeks prior to the trial; 6) Chemical peel treatments within 2 weeks prior to the trial; 7) Oral retinoid use within 2 months prior to the trial (6 months for acitretin); 8) Topical tacrolimus use within 3 months prior to the trial; 9) Facial energy-based procedures (laser/IPL/RF), injectable treatments (including hydrodermabrasion), or surgeries within 2 months prior to the trial; 10) Emotionally unstable individuals or those with unrealistic outcome expectations; 11) Keloid predisposition, trypanophobia, or inability to comply with follow-up.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total effective rate at the end of week 18; | — |
Countries
China
Contacts
Public ContactZhonglan Pan
Nanjing Yijia Aesthetic Clinic
Outcome results
None listed